Abstracts (HTML) List of Authors

Naas, S

Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland

Nagao, A

Long-term efficacy and safety of rIX-FP prophylaxis in adult patients with haemophilia B on a 21-day dosing regimen

Nagel, G

Light-induced ion influx triggers megakaryocyte polarization

Nagler, M

A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland

Nagy, M

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Nagy, Z

Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation

Negrier, C

An analysis of fatalities in persons with congenital hemophilia A (PwcHA) reported in the FDA Adverse Event Reporting System (FAERS) database

Négrier, C

Long-term Efficacy and Safety of Fitusiran in Participants with Hemophilia A and B: An Interim Analysis of the Phase 1/2 Open-Label Extension Study

Nemani, A

Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.

Nestler, P

Platelets from patients with MYH9 related disorders are mechanically stiffer

Neudorf, U

Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.

Ní Áinle, F

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Nicoletti, TF

Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.

Nimmerjahn, F

A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)

Nimtz-Talaska, A

Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication

Nolli, S

Insight into the role of miR-223-3p in regulating platelet reactivity

Nolte, MW

Characterization of rFIX fusion proteins enabling subcutaneous administration
In vitro characterization of K5A and K5R variants of Factor IX

Nopp, S

Growth differentiation factor-15 predicts major cardiac adverse events and all-cause mortality in patients with atrial fibrillation

Noris, P

Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Núñez, R

A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII